PHIONasdaqPharmaceutical PreparationsFiscal year ends December 31
Phio Pharmaceuticals Corp.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$0.87−0.00 (-0.25%)
Close on Oct 19, 2026
- Market cap
- $10.09M
- P/E (TTM)
- –
- Dividend yield
- –
Phio Pharmaceuticals statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Pharmaceutical Preparations companies for comparison
Valuation
| Measure | Phio Pharmaceuticals | Industry median |
|---|---|---|
| Market Cap | $10.09M | $166.30M |
| Enterprise Value | -$2.90M | $88.19M |
| PB Ratio | 0.80 | 2.03 |
| P/TBV Ratio | 0.80 | 2.29 |
Income (trailing twelve months)
| Measure | Phio Pharmaceuticals | Industry median |
|---|---|---|
| Operating Income | -$13.47M | -$21.40M |
| Net Income | -$12.90M | -$22.46M |
| EBITDA | -$13.47M | -$16.91M |
| EPS (Diluted) | -$1.39 | -$0.83 |
Returns
| Measure | Phio Pharmaceuticals | Industry median |
|---|---|---|
| Return on Equity (ROE) | -113.7% | -53.2% |
| Return on Assets (ROA) | -100.8% | -40.9% |
Balance sheet
| Measure | Phio Pharmaceuticals | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $13.00M | $61.43M |
| Net Cash (Debt) | $13.00M | $15.35M |
| Net Cash Per Share | $1.12 | $0.66 |
| Equity (Book Value) | $12.60M | $49.09M |
| Book Value Per Share | $1.08 | $1.37 |
| Tangible Book Value | $12.60M | $23.52M |
Cash flow (trailing twelve months)
| Measure | Phio Pharmaceuticals | Industry median |
|---|---|---|
| Operating Cash Flow | -$12.20M | -$12.35M |
| Capital Expenditures | -$7.00K | -$1.08M |
| Free Cash Flow | -$12.21M | -$20.22M |
| FCF Per Share | -$1.05 | -$0.42 |
Efficiency
| Measure | Phio Pharmaceuticals | Industry median |
|---|---|---|
| Profits Per Employee | -$2.15M | -$703.34K |
| Employee Count | 6 | 74 |
Dividends and yields
| Measure | Phio Pharmaceuticals | Industry median |
|---|---|---|
| Earnings Yield | -127.8% | -23.3% |
| FCF Yield | -121.0% | -8.72% |
Shares
| Measure | Phio Pharmaceuticals | Industry median |
|---|---|---|
| Shares Outstanding | 11,617,300 | 58,127,000 |
| Shares Change (YoY) | 238.9% | 10.9% |
| Shares Change (QoQ) | 0.00% | 0.54% |
| Float | 10,412,800 | 49,136,700 |
| Shares Held by Insiders | 10.4% | 11.6% |
| Shares Held by Institutions | 5.57% | 59.4% |
Scores
| Measure | Phio Pharmaceuticals | Industry median |
|---|---|---|
| Altman Z-Score | -15.53 | -0.22 |
Calculated by StockData from Phio Pharmaceuticals's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.